Split GFP technologies to structurally characterize and quantify functional biomolecular interactions of FTD-related
Chiara Foglieni1, Stéphanie Papin1, Agnese Salvadè1
1Laboratory for Biomedical Neurosciences, Neurocenter of Southern Switzerland, Torricella-Taverne, Switzerland.
Scientific Reports
|October 27, 2017
Summary
Protein multimerization is key in neurodegenerative diseases. This study uses split GFP technologies to analyze TDP-43 oligomerization, revealing structural factors critical for understanding frontotemporal dementia and ALS.
Area of Science:
- Neurobiology
- Molecular Biology
- Biochemistry
Background:
- Protein multimerization is integral to neurodegenerative diseases.
- TDP-43, linked to ALS and FTD, forms functional nuclear oligomers; destabilization precedes pathology.
- Understanding TDP-43 oligomerization mechanisms is crucial for neurodegeneration research.
Purpose of the Study:
- To investigate the structural determinants of TDP-43 self-assembly using split GFP technologies.
- To quantitatively and qualitatively define TDP-43 oligomerization in a cellular context.
- To demonstrate the utility of GFP bimolecular and trimolecular fluorescence complementation (biFC and triFC) for studying protein multimerization in neurodegeneration.
Main Methods:
- Parallel implementation of GFP bimolecular (biFC) and trimolecular (triFC) fluorescence complementation.
- Application of orthogonal assays to analyze TDP-43 self-assembly.
- In situ analysis of protein localization and multimerization dynamics.
Main Results:
- Successfully applied biFC and triFC to study TDP-43 oligomerization.
- Defined structural factors influencing TDP-43 self-assembly qualitatively and quantitatively.
- Demonstrated the effectiveness of GFP-based complementation assays for neurodegenerative protein studies.
Conclusions:
- Split GFP technologies (biFC and triFC) are versatile tools for studying protein multimerization in neurodegeneration.
- These methods provide insights into the structural basis of TDP-43 oligomerization.
- Understanding TDP-43 oligomerization is vital for developing therapeutic strategies for FTD and ALS.


